Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

VolitionRX Q1 2024 GAAP EPS $(0.10) Beats $(0.11) Estimate, Sales $171.535K Miss $389.500K Estimate

Author: Benzinga Newsdesk | May 13, 2024 04:57pm
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $171.535 thousand which missed the analyst consensus estimate of $389.500 thousand by 55.96 percent. This is a 14.50 percent increase over sales of $149.808 thousand the same period last year.

Posted In: VNRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist